Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits 
Telegram Restored on Apple App Store After Temporary Removal 
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Apple Restores Telegram to App Store After Content Policy Violation 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
Global Bioenergies to present at the Microcap investors conference in New-York, on the 10th of April 2018
Evry, France - 06 April 2018 - Global Bioenergies to present at the Microcap investors conference in New-York, on the 10th of April 2018. For the First time in North America, the technology and business model of the company will be exposed in front of a selection of institutional investors.
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performance of its process, to operate its demo plant in Germany, and to prepare the first full-scale plant through a joint venture with Cristal Union, named IBN-One. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).
Stay informed! Subscribe to our newsfeed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Jean-Baptiste Barbaroux
Chief Corporate Officer
Phone: +33 1 64 98 20 50
[email protected]
Attachment
